A. Cutting-edge issues in population health and personalized medicine:
- Professor Young Joon Surh, Professor & Director, Tumor Microenvironment Global Core Research Center, Seoul, Korea – Dietary factors and mechanisms for cancer prevention and intervention.
- Professor Laura Rudkin, Chairman, Department of Preventive Medicine and Community Health, University of Texas Medical Branch, Galveston, Texas, USA – Significant contributions of social factors on innovative improvement of population health and personalized medicine.
- Professor J Bian, Dean, Shantou University Medical College, Shantou, China) – Training future medical care professionals and practical application of precision medicine for healthy populations.
B. Basic science and translation of scientific knowledge into clinical applications:
- Professor David Phillips, King’s College London, UK – Mutational Signatures as Clues to Cancer Aetiology and Carcinogenic Mechanism.
- Professor William Au, University of Texas Medical Branch, USA, Shantou University Medical College, China and University of Medicine and Pharmacy at Tirgu Mures, Romania –Involvement of inherent DNA repair variations in the development, prevention, intervention and prognosis of cancer.
- Professor Alberto Izzotti, Chairman, University of Genoa, Genoa, Italy – microRNA on post-transcriptional gene expression and on causation of health consequences.
- Professor Thomas Hofmann, German Cancer Research Center (DKFZ), Germany – Cellular Decision-Making Between Life and Death by HIPK2 and P53 Upon Genotoxic Damage.
- Professor Minodora Dobreanu, Director, University of Medicine and Pharmacy, Tirgu Mures, Romania – Application of laboratory medicine technology for significant improvement in precision medicine.
- Professor Jianzhen Xu, Director Bioinformatics Laboratory, Shantou University Medical College, Shantou, China – Application of bioinformatic expertise towards enhancement of population health and precision medicine.
C. Clinical applications of precision and personalized medicine:
- Professor Elmer Nimmesgern, European Commission, Innovative and Personalised Medicine Unit, Health Directorate, Directorate-General Research and Innovation, Brussels, Belgium
- Marius Geanta: President, Center for Innovations in Medicine, Bucharest, Romania – Use of innovative approaches in personalized medicine to significantly achieve efficacy, reduced cost and less suffering”
- Professor Manuela Neuman: Head of Toxicology Department, University of Toronto, Canada. – Integration of personalized treatment approaches to enhance clinical outcomes via correct use of natural products and therapeutics.
- Rector Leonard Azamfirei, University of Medicine and Pharmacy, Tirgu Mures, Romania –Enhancement of critical care medicine using precision and personalized approaches.